HAL (France)open access
ID Card of Mcl-1 PROTAC degrader: From in silico design to biological validation in chemoresistant ovarian cancer
0, Mcl-1, Ovarian cancer, 1, PROTAC, Oligopyridine, Targeted protein degradation
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 280401
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.